Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. Current Liabilities for the year ending December 31, 2023: USD 30.52 M

Pharmanutra S.p.A. Current Liabilities is USD 30.52 M for the year ending December 31, 2023, a 10.59% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Pharmanutra S.p.A. Current Liabilities for the year ending December 31, 2022 was USD 27.59 M, a 44.73% change year over year.
Pharmanutra S.p.A. Current Liabilities for the year ending December 31, 2021 was USD 19.07 M, a 40.05% change year over year.
Pharmanutra S.p.A. Current Liabilities for the year ending December 31, 2020 was USD 13.61 M, a -25.46% change year over year.
Pharmanutra S.p.A. Current Liabilities for the year ending December 31, 2019 was USD 18.26 M, a 23.04% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	112
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Key trends

Past 5 years